| Abel, Keith A.; Boyer, John-Christopher; Veggel, Frank C. J. M. van (2009). Hard Proof of the NaYF4/NaGdF4 Nanocrystal Core/Shell Structure. Journal of the American Chemical Society 131(41) , 14644-14645. 10.1021/ja906971y. |
SGM |
Peer-Reviewed Article |
|
| Abad, Manuel David; Sanjinés, Rosendo; Endrino, Jose Luis; Gago, Raúl; Andersson, Joakim et al. (2011). Identification of Ternary Phases in TiBC/a-C Nanocomposite Thin Films: Influence on the Electrical and Optical Properties. Plasma Processes and Polymers 8(7) , 579-588. 10.1002/ppap.201000182. |
SGM, VLS-PGM |
Peer-Reviewed Article |
|
| Aaron Yamniuk; Anish Suri; James Bryson; James Tamura; Philip Drew et al. (2016). cd40 antagonizing antibody polypeptides. Patent Number: BR112013026828A2. |
|
Patent |
|
| ãã£ãªãã ãªã³ã³ãã«ãã¸ã§ã¤ã ãº; Philip O'connell James; ããã¼ã ãã¼ã¿ã¼ãã¸ã§ã³; Robert Porter John; ãã¼ã½ã³ãã¢ã©ã¹ã㢠et al. (2023). Novel TNFα structures for use in therapy. Patent Number: JP2023100010A. |
|
Patent |
|
| ãã£ãªãã ãªã³ã³ãã«ãã¸ã§ã¤ã ãº; Philip O'connell James; ãã£ãªãã ãªã³ã³ãã«ãã¸ã§ã¤ã ãº; ããã¼ã ãã¼ã¿ã¼ãã¸ã§ã³; Robert Porter John et al. (2021). New TNFα structure for therapeutic use. Patent Number: JP2021109880A. |
|
Patent |
|
| ãã£ãªãã ãªã³ã³ãã«ãã¸ã§ã¤ã ãº; ããã¼ã ãã¼ã¿ã¼ãã¸ã§ã³; ãã¼ã½ã³ãã¢ã©ã¹ãã¢; ã¯ãã¼ããªã¢ã³ãããªã¹; ã¨ãã¯ã¼ã ã©ããããã¹ãã£ã¼ãã³ et al. (2023). Novel TNFα structures for use in therapy. Patent Number: JP7336178B2. |
|
Patent |
|
| 6. Stephen L. Christensen (2013). Structure and Bonding in Thiolate-Coated Au Nanostructures. Supervisor: Zhang, Peng & Chatt, Amares. NS, Canada: Dalhousie University. http://dalspace.library.dal.ca/handle/10222/21912?show=full. |
CLS-APS |
Doctoral Thesis |
|
| 44. Joseph Daniel Padmos (2015). Understanding the Structure of Silver Nanoparticles and Its Influence on Surface Reactivity. Supervisor: Zhang, Peng. NS, Canada: Dalhousie University. http://dalspace.library.dal.ca/handle/10222/64673. |
CLS-APS, HXMA, SXRMB |
Doctoral Thesis |
|
| 한 리; 도로씨아 코미노스; 지에 장; 알라 프리츠커; 매튜 데이비슨 et al. (2020). Antibodies to bradykinin b1 receptor ligands. Patent Number: KR102166083B1. |
|
Patent |
|
| 한 리; 도로씨아 코미노스; 지에 장; 알라 프리츠커; 매튜 데이비슨 et al. (2022). Antibodies to bradykinin b1 receptor ligands. Patent Number: KR20220031728A. |
|
Patent |
|
| 한 리; 도로씨아 코미노스; 지에 장; 알라 프리츠커; 매튜 데이비슨 et al. (2019). Antibodies to bradykinin b1 receptor ligands. Patent Number: KR102035882B1. |
|
Patent |
|
| 한 리; 도로씨아 코미노스; 지에 장; 알라 프리츠커; 매튜 데이비슨 et al. (2022). Antibodies to bradykinin b1 receptor ligands. Patent Number: KR102367723B1. |
|
Patent |
|
| 민 수; 메르세데츠 발라즈; 닝 차이; 낸시 치앙; 헨리 치우 et al. (2015). Anti-hemagglutinin antibodies and methods of use. Patent Number: KR20150083124A. |
|
Patent |
|
| 본 크로덴슈타인 토마스 스프리터; 서짓 비마라오 딕시트; 카브레라 에릭 에스코바; 폴라 아이린 라리오; 데이빗 카이 위엔 푼 et al. (2019). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: KR102052774B1. |
|
Patent |
|
| 제이. 마이클 엘리오트; 저스틴 쉬르 (2018). Fc VARIANTS AND METHODS FOR THEIR PRODUCTION. Patent Number: KR101913448B1. |
|
Patent |
|